Results 221 to 230 of about 2,293,436 (352)

Annual highlights of programs in energy science. [Chemistry; materials; process]

, 1978

openalex   +2 more sources

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Exogenous Physical Irradiation on Titania Semiconductors: Materials Chemistry and Tumor-Specific Nanomedicine. [PDF]

Adv Sci (Weinh), 2018
Zhang R, Yan F, Chen Y.
europepmc   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

AlbiCDN: albumin-binding amphiphilic STING agonists augment the immune activity for cancer immunotherapy. [PDF]

RSC Med Chem
Zhuo SH, Chen X, Zhao L, Wang TY, Su JY, Yang T, Yang L, Dong F, Zhao YF, Li YM.   +9 more
europepmc   +1 more source

Physical descriptor for the Gibbs energy of inorganic crystalline solids and temperature-dependent materials chemistry. [PDF]

Nat Commun, 2018
Bartel CJ, Millican SL, Deml AM, Rumptz JR, Tumas W, Weimer AW, Lany S, Stevanović V, Musgrave CB, Holder AM.   +9 more
europepmc   +1 more source

Materials Chemistry and Physics

, 1983

openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Strategies Based on Nitride Materials Chemistry to Stabilize Li Metal Anode. [PDF]

Adv Sci (Weinh), 2017
Zhu Y, He X, Mo Y.
europepmc   +1 more source

New Materials: Chemistry and Physics [PDF]

Science, 1990
openaire   +3 more sources